THE PATHOLOGY OF MELANOMAAN INTERNATIONAL COURSE

Course 2018

Objectif

Following the success of first Course in 2017, the goal of this updated Second Annual Course is to address the most difficult diagnostic problems encountered by practicing pathologists in cutaneous and ocular melanoma.

The approach of the Course will be practical based on the extensive experience of the Director, Co-Directors, and Speakers in the Course. The Course will consist of didactic lectures and interactive sessions during the two-day period. Digitized images of specific cases will be available for review in advance of the Course and will be discussed in the interactive sessions of the Course.

Selected topics will include the general approach to the difficult melanocytic lesion, dysplastic and other atypical cutaneous melanocytic nevi, spitzoid melanocytic neoplasms, blue nevi and atypical variants, nevoid melanoma, desmoplastic melanoma, blue nevus-like melanoma, conventional cutaneous melanoma, primary acquired melanosis, pediatric melanoma, acral melanoma, mucosal melanoma, melanocytic lesions of the nail apparatus, conjunctival melanoma, uveal melanoma, the reporting of melanoma and prognostic factors, what the clinician expects from the pathologist, the assessment of margins and sentinel lymph node, AJCC guidelines 8th Edition for melanoma staging, practical immunohistochemistry and practical molecular analysis of melanocytic lesions, and immune checkpoint pathways.

Speakers

DIRECTORS

Pr Raymond Barnhill,
Institut Curie and University of Paris Descartes, Paris, France

Pr Klaus Busam,
Memorial Sloan Kettering Cancer Center, New York, USA

Pr David Elder,
University of Pennsylvania, Philadelphia USA

Pr Richard Scolyer,
Royal Prince Alfred Hospital, Melanoma Institute of Australia and the University of Sydney, Sydney, Australia

OTHER SPEAKERS

Dr Boris Bastian,
University of California, San Francisco, USA

Pr Nathalie Cassoux,
Institut Curie, Paris, France

Dr Loren Clarke,
Myriad Genetic Laboratories, Salt Lake City, USA

Dr Arnaud de la Fouchardière,
Centre Léon Bérard, Lyon, France

Dr Laurence Desjardins,
Institut Curie, Paris, France

Pr Alan Spatz,
McGill University, Montreal Canada

Pr Artur Zembowicz,
Tufts Medical School, Boston, USA

Non exhaustive list of topics

  • General approach to the difficult melanocytic lesion
  • Congenital nevi and related lesions
  • Acquired melanocytic nevi and including unusual and special variants
  • Dysplastic nevi
  • Spitzoid melanocytic neoplasms
  • Blue nevi and atypical variants
  • Nevoid, lentigo maligna, desmoplastic, blue nevus-like, conventional cutaneous, pediatric, acral, mucosal, conjunctival and uveal melanomas
  • Melanocytic lesions of the nail apparatus
  • Conjunctival melanocytic lesions including nevi and melanosis
  • AJCC guidelines (8th Edition) for cutaneous and ocular melanoma staging
  • Practical immunohistochemistry
  • Practical molecular analysis of melanocytic lesions
  • Immune checkpoint pathways
  • The reporting of melanoma and prognostic factors
  • What the clinician expects from the pathologist